We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

AusPAR: Apixaban

Australian Public Assessment Report

AusPAR

AusPAR: Apixaban [PDF, 845.49 KB]

AusPAR: Apixaban [Word, 930.43 KB]

Attachment: Product Information: Apixaban [PDF, 754.19 KB]

Attachment: Product Information: Apixaban [Word, 671.91 KB]

Attachment: Extract from Clinical Evaluation Report: Apixaban [PDF, 752.26 KB]

Attachment: Extract from Clinical Evaluation Report: Apixaban [Word, 1 MB]

Device/Product Name

Eliquis

Active ingredients

Apixaban

AusPAR Date

21 June 2013

Published

28 August 2013

Submission Number

PM-2011-03165-3-3

Submission Type

Extension of indications

Decision

Approved